The Therapeutic Pipeline: Future Treatments and Precision Medicine
Year: 2026
Type: article
DOI: 10.1055/a-3004-0630
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: acid sphingomyelinase deficiency, pulmonary alveolar proteinosis, pulmonary Langerhans cell histiocytosis, precision medicine, enzyme replacement therapy, olipudase alfa, gene therapy, genome editing, inhaled GM-CSF, molgramostim, MAPK signaling, BRAF inhibitors, MEK inhibitors, surfactant homeostasis, lysosomal dysfunction, radiomics, artificial intelligence, biomarkers, patient stratification
Open Access status: closed
OpenAlex ID: W7225983862
